Volume 87 Issue 14 | p. 17 | Concentrates
Issue Date: April 6, 2009

Sutro Advances Cell-Free Proteins

Department: Business

Sutro Biopharma has produced a therapeutic cytokine protein at 100-L scale using a cell-free synthesis technology. The achievement triggered a $15 million investment by venture capital investors. South San Francisco-based Sutro says it employs controlled, catalytically driven biochemical reactions to make protein-based therapeutics without the constraints of the cell wall and membrane. The firm licensed its technology from James R. Swartz, a Stanford University chemical engineering professor.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment